Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.
| Revenue (Most Recent Fiscal Year) | $14.24B |
| Net Income (Most Recent Fiscal Year) | $1.59B |
| PE Ratio (Current Year Earnings Estimate) | 31.52 |
| PE Ratio (Trailing 12 Months) | 34.23 |
| PEG Ratio (Long Term Growth Estimate) | 2.52 |
| Price to Sales Ratio (Trailing 12 Months) | 7.31 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 5.50 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 25.24 |
| Pre-Tax Margin (Trailing 12 Months) | 14.61% |
| Net Margin (Trailing 12 Months) | 12.06% |
| Return on Equity (Trailing 12 Months) | 16.63% |
| Return on Assets (Trailing 12 Months) | 9.24% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.32 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.82 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.44 |
| Inventory Turnover (Trailing 12 Months) | 1.90 |
| Book Value per Share (Most Recent Fiscal Quarter) | $13.33 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.56 |
| Earnings per Share (Most Recent Fiscal Year) | $2.05 |
| Diluted Earnings per Share (Trailing 12 Months) | $1.19 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 1.47B |
| Free Float | 1.46B |
| Market Capitalization | $107.48B |
| Average Volume (Last 20 Days) | 6.23M |
| Beta (Past 60 Months) | 0.78 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.50% |
| Percentage Held By Institutions (Latest 13F Reports) | 89.07% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |